Scribe Therapeutics Upsizes IPO & Prices it at $15 – Top of Range
By
JOIN THE CONVERSATION
Subscribe
Connect with
Login
I allow to create an account
When you login first time using a Social Login button, we collect your account public profile information shared by Social Login provider, based on your privacy settings. We also get your email address to automatically create an account for you in our website. Once your account is created, you'll be logged-in to this account.
DisagreeAgree
Connect with
I allow to create an account
When you login first time using a Social Login button, we collect your account public profile information shared by Social Login provider, based on your privacy settings. We also get your email address to automatically create an account for you in our website. Once your account is created, you'll be logged-in to this account.
DisagreeAgree
0 Comments
Oldest
Newest
Most Voted
Top stories
FBI Arrests Chinese Woman At LAX For Surveilling Son Of Taiwanese President
Authored by Lear Zhou via The Epoch Times, The…
Religious Roots, Legislation, and Public Debate: PA Senator Doug Mastriano’s Post Sparks Viral Online Conversation
POLITICS & SOCIETY | By National Desk | Updated…
Congressman Scott Perry Exposes Major Washington Overreach During Live TeleTown Hall
Rep. Scott Perry (R-PA) recently connected with constituents across…
Zelenskyy Confirms He Will Not Step Down Amid Ongoing Wartime Crimes
Geopolitical & Strategic Assessment: The Office of the President…
Massive Darth Vader Episode II Premiere Secrets Finally Revealed After Years of Waiting
The anticipation surrounding independent and fan-made Star Wars projects…
Senate Blocks Report on Deaths of 9 Americans in the West Bank After Key 47–51 Vote
WASHINGTON, D.C. — In a 47–51 roll-call vote, the…
Rep Perry Unveils Major HEATS Act Legislation in Crucial House Debate
As Capitol Hill navigates a packed legislative calendar, federal…
Related Articles
OPay Prices Nigeria IPO at $19 Low End
By
1 Min Read
BHAV Acquisition II Raises $100 Million in IPO
By
1 Min Read
Bambusa Therapeutics Launches $150 Million IPO
By
1 Min Read